Advertisement

Table of Contents

March 01, 1982; Volume 21,Issue 2

You have access
Conformational requirements of alpha 2-adrenergic receptors.
R R Ruffolo, K S Anderson and D D Miller

Molecular Pharmacology March 1982, 21 (2) 259-261;
You have access
Production of hydroxyl radical by decomposition of superoxide spin-trapped adducts.
E Finkelstein, G M Rosen and E J Rauckman

Molecular Pharmacology March 1982, 21 (2) 262-265;
You have access
Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.
A Pfeiffer and A Herz

Molecular Pharmacology March 1982, 21 (2) 266-271;
You have access
[3H]Etorphine receptor binding in vivo. Small fractional occupancy elicits analgesia.
D C Perry, J S Rosenbaum, M Kurowski and W Sadée

Molecular Pharmacology March 1982, 21 (2) 272-279;
You have access
In vivo regulation of muscarinic cholinergic receptors in embryonic chick brain.
M R Meyer, M W Gainer and N M Nathanson

Molecular Pharmacology March 1982, 21 (2) 280-286;
You have access
Cooperativity pattern in the interaction of the antiestrogen drug clomiphene with the Muscarinic receptors.
G Ben-Baruch, G Schreiber and M Sokolovsky

Molecular Pharmacology March 1982, 21 (2) 287-293;
You have access
In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
P M Laduron, P F Janssen, W Gommeren and J E Leysen

Molecular Pharmacology March 1982, 21 (2) 294-300;
You have access
[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
J E Leysen, C J Niemegeers, J M Van Nueten and P M Laduron

Molecular Pharmacology March 1982, 21 (2) 301-314;
You have access
Differential stereoselectivity of methotrimeprazine enantiomers for selected central nervous system receptor types.
T A Robert, A N Hagardorn and E A Daigneault

Molecular Pharmacology March 1982, 21 (2) 315-319;
You have access
Interactions of barbiturates of various pharmacological categories with benzodiazepine receptors.
F Leeb-Lundberg and R W Olsen

Molecular Pharmacology March 1982, 21 (2) 320-328;
You have access
Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.
R R Goodman, M J Cooper, M Gavish and S H Snyder

Molecular Pharmacology March 1982, 21 (2) 329-335;
You have access
Stimulation of a low Km GTPase by inhibitors of adipocyte adenylate cyclase.
K Aktories, G Schultz and K H Jakobs

Molecular Pharmacology March 1982, 21 (2) 336-342;
You have access
Structure of the saxitoxin binding site at sodium channels in nerve membranes. Exchange of tritium from bound toxin molecules.
G Strichartz

Molecular Pharmacology March 1982, 21 (2) 343-350;
You have access
Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes.
C E Spivak, M A Maleque, A C Oliveira, L M Masukawa, T Tokuyama, J W Daly and E X Albuquerque

Molecular Pharmacology March 1982, 21 (2) 351-361;
You have access
Characterization of serotonin uptake in cultured neuroblastoma cells. Difference between differentiated and nondifferentiated cells.
J R Yoffe and R T Borchardt

Molecular Pharmacology March 1982, 21 (2) 362-367;
You have access
Characterization of serotonin uptake in cultured pheochromocytoma cells. Comparison with norepinephrine uptake.
J R Yoffe and R T Borchardt

Molecular Pharmacology March 1982, 21 (2) 368-373;
You have access
A structure-activity study of the transport sites for the hypothalamic and striatal catecholamine uptake systems. Similarities and differences.
S B Eckhardt, R A Maxwell and R M Ferris

Molecular Pharmacology March 1982, 21 (2) 374-379;
You have access
Chemical transformations of xylamine (N-2'-chloroethyl-N-ethyl-2-methylbenzylamine) in solution. Pharmacological activity of the species derived from this irreversible norepinephrine uptake inhibitor.
R W Ransom, R C Kammerer and A K Cho

Molecular Pharmacology March 1982, 21 (2) 380-386;
You have access
Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
K J Fehske, U Schläfer, U Wollert and W E Müller

Molecular Pharmacology March 1982, 21 (2) 387-393;
You have access
Structure-activity relationships in the ansamycins. Molecular structure and activity of 3-carbomethoxy rifamycin S.
M Brufani, L Cellai, S Cerrini, W Fedeli, A Segre and A Vaciago

Molecular Pharmacology March 1982, 21 (2) 394-399;
You have access
Comparison of crystallographic and quantum mechanical analysis with biological data on clonidine and some related analogues.
A Carpy, J M Leger, G Leclerc, N Decker, B Rouot and C G Wermuth

Molecular Pharmacology March 1982, 21 (2) 400-408;
You have access
Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation.
S G Dahl, M Hjorth and E Hough

Molecular Pharmacology March 1982, 21 (2) 409-414;
You have access
Magnesium-dependent inhibition of beef heart soluble mitochondrial adenosine triphosphatase by tricyclic antipsychotics.
P Palatini

Molecular Pharmacology March 1982, 21 (2) 415-421;
You have access
Effects of the calmodulin antagonist trifluoperazine on stimulus-induced calcium mobilization, aggregation, secretion, and protein phosphorylation in platelets.
M B Feinstein and R A Hadjian

Molecular Pharmacology March 1982, 21 (2) 422-431;
You have access
Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus.
J A Fyfe

Molecular Pharmacology March 1982, 21 (2) 432-437;
You have access
Rates of alcohol dehydrogenase-dependent ethanol metabolism in periportal and pericentral regions of the perfused rat liver.
T Kashiwagi, S Ji, J J Lemasters and R G Thurman

Molecular Pharmacology March 1982, 21 (2) 438-443;
You have access
Cysteine S-conjugate N-acetyltransferase from rat kidney microsomes.
M W Duffel and W B Jakoby

Molecular Pharmacology March 1982, 21 (2) 444-448;
You have access
Induction and modification of rat liver microsomal arylamide N-hydroxylase by various pretreatments.
C Razzouk, M Batardy-Grégoire and M Roberfroid

Molecular Pharmacology March 1982, 21 (2) 449-457;
You have access
Norcocaine nitroxide. A potential hepatotoxic metabolite of cocaine.
E J Rauckman, G M Rosen and J Cavagnaro

Molecular Pharmacology March 1982, 21 (2) 458-463;
You have access
Inhibition of rat liver cytochrome P-450 by benzyl hydrodisulfide.
T Sawahata and R A Neal

Molecular Pharmacology March 1982, 21 (2) 464-467;
You have access
Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
R I Glazer and L S Lloyd

Molecular Pharmacology March 1982, 21 (2) 468-473;
You have access
In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
W C Tseng, D Derse, Y C Cheng, R W Brockman and L L Bennett

Molecular Pharmacology March 1982, 21 (2) 474-477;
You have access
Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
B A Domin, S P Grill, K F Bastow and Y C Cheng

Molecular Pharmacology March 1982, 21 (2) 478-482;
You have access
Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18tG2 and neuroblastoma x glioma NG108-15 hybrid cell lines.
P Y Law, J E Koehler and H H Loh

Molecular Pharmacology March 1982, 21 (2) 483-491;
You have access
Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporation.
P Y Law, T D Nicksic, M A O'Rourke, J E Koehler, A Herz and H H Loh

Molecular Pharmacology March 1982, 21 (2) 492-502;
You have access
Cyclic AMP receptors and cation fluxes in the turkey erythrocyte.
S A Rudolph, T M Baird and J W Wardell

Molecular Pharmacology March 1982, 21 (2) 503-510;
You have access
Differential inducibility of nuclear envelope epoxide hydratase by trans-stilbene oxide and phenobarbital.
F J Gonzalez and C B Kasper

Molecular Pharmacology March 1982, 21 (2) 511-516;
You have access
Cytochrome P-450 and monooxygenase activity in cardiac microsomes from the fish Stenotomus chrysops.
J J Stegeman, B R Woodin, A V Klotz, R E Wolke and N R Orme-Johnson

Molecular Pharmacology March 1982, 21 (2) 517-526;
You have access
Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
L M Bornheim and M R Franklin

Molecular Pharmacology March 1982, 21 (2) 527-532;